 |
The Journal of Neuroscience, August 13, 2003, 23(19):7385-7394
Previous Article | Next Article 
p75 Neurotrophin Receptor Protects Primary Cultures of Human Neurons against Extracellular Amyloid Peptide Cytotoxicity
Yan Zhang,2,4
Yanguo Hong,4
Younes Bounhar,2,4
Megan Blacker,4
Xavier Roucou,4
Omar Tounekti,4
Emily Vereker,4
William J. Bowers,1
Howard J. Federoff,1
Cynthia G. Goodyer,3 and
Andréa LeBlanc2,4
1Department of Neurology and Center for Aging and
Developmental Biology, University of Rochester, Rochester, New York 14642,
Departments of 2Neurology and Neurosurgery and
3Pediatrics, McGill University, Montreal, Quebec,
Canada H3A 2B4, and 4Lady Davis Institute for Medical
Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec,
Canada H3T 1E2
The cytotoxicity of extracellular amyloid peptide (A ) has been
clearly demonstrated in many cell types. In contrast, primary human neurons in
culture are resistant to extracellular A -mediated toxicity. Here, we
investigate the involvement of p75 neurotrophin receptor (p75NTR)
in A -treated human neurons. We find that
A 1-40 and
A 1-42, but not the reverse control
peptide, A 40-1, rapidly increase the
levels of p75NTR in a specific and dose-dependent manner. In
contrast to observations in cell lines, enhanced expression of
p75NTR in human neurons via a herpes simplex virus amplicon vector
does not increase the susceptibility of neurons to A . Unexpectedly,
inhibition of p75NTR expression with an antisense expression
construct or incubation of the cells with an antibody to the extracellular
domain of p75NTR sensitizes human neurons to extracellular
nonfibrillar or fibrillar A 1-42 cytotoxicity. Unlike
intracellular A , extracellular A toxicity is independent of p53
and Bax activity. However, A toxicity is inhibited by caspase inhibitors
and the glycogen synthase kinase 3 inhibitor lithium. Neuroprotection
against A is phosphatidylinositide 3-kinase dependent but Akt
independent. These results are consistent with a neuroprotective role for
p75NTR against extracellular A toxicity in human neurons.
Key words: Alzheimer; primary human neurons; p75 neurotrophin receptor; amyloid peptide; neurotoxicity; neuroprotection
Received Apr. 2, 2003;
revised Jun. 16, 2003;
accepted Jun. 18, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
N. Yamamoto, E. Matsubara, S. Maeda, H. Minagawa, A. Takashima, W. Maruyama, M. Michikawa, and K. Yanagisawa
A Ganglioside-induced Toxic Soluble Abeta Assembly: ITS ENHANCED FORMATION FROM AbetaBEARING THE ARCTIC MUTATION
J. Biol. Chem.,
January 26, 2007;
282(4):
2646 - 2655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Magrane, K. M. Rosen, R. C. Smith, K. Walsh, G. K. Gouras, and H. W. Querfurth
Intraneuronal {beta}-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response
J. Neurosci.,
November 23, 2005;
25(47):
10960 - 10969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lesne, C. Gabriel, D. A. Nelson, E. White, E. T. MacKenzie, D. Vivien, and A. Buisson
Akt-dependent Expression of NAIP-1 Protects Neurons against Amyloid-{beta} Toxicity
J. Biol. Chem.,
July 1, 2005;
280(26):
24941 - 24947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Jhamandas and D. MacTavish
Antagonist of the Amylin Receptor Blocks {beta}-Amyloid Toxicity in Rat Cholinergic Basal Forebrain Neurons
J. Neurosci.,
June 16, 2004;
24(24):
5579 - 5584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|